-The Economic Times The Delhi High Court on Friday quashed criminal proceedings against Microsoft India, a fortnight after the company was exempted by a trial court in a similar case for hosting objectionable content online.  Microsoft India is the only company, out of the 21 websites, against whom both criminal and civil proceedings pending in the capital's High Court and trial court now stand quashed.  Justice Suresh Kait set aside the trial court's...

As the biotech industry takes heart from the prime minister’s remark, a fresh report shows India’s regulation and expertise on GM crops are sloppy BUOYED by the prime minister’s remark that NGOs were responsible for the moratorium on the release of GM or Bt brinjal, the biotech industry is stepping up its campaign to get it lifted along with “all constraints in the research and development work of biotech crops”. It...

-The Telegraph Lakshman Seth, the former CPM member of Parliament blamed for much of the bloodshed in Nandigram, was arrested by a Bengal police team this afternoon while hiding in a Mumbai guesthouse along with two party colleagues. Seth, former MLA Amiya Sahoo and East Midnapore leader Ashok Guria are the key accused in the alleged killing of six villagers during the CPM’s “recapture” of Nandigram in November 2007. Seth, entangled in...

Most of us don’t even get a single shot at making history — Manmohan Singh has a second chance The fiscal deficit is an outcome, not a policy. It is the net resolution of the policies pertaining to taxes and expenditure. It is worth analysing separately the two components of the deficit. The table reports the results of relating the tax and expenditure share of GDP to per capita income for...

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...